Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vallance

Showing results (101-110 of 1,388) with videos related to

Pageof 139
Sort By:
Critical Reviews in Clinical Laboratory Sciences|October 30, 2003
Carrier testing for autosomal-recessive disordersHilary Vallance, Jason Ford
Australasian Radiology|November 1, 1993
Retrograde venography and colour Doppler imaging of a popliteal venous aneurysmC Fernando, S Vallance
BMJ (Clinical Research Ed.)|February 16, 2008
Measuring patient care: PROMs promote health gain and patient involvementAndrew J Vallance-Owen
Journal of the American Society of Nephrology : JASN|July 1, 2005
Asymmetric dimethylarginine and kidney disease--marker or mediator?Patrick Vallance, James Leiper
Cardiovascular Research|February 1, 1994
Drugs that alter nitric oxide homeostasis: a replyP Vallance, S Moncada
Clinical Pharmacology and Therapeutics|September 14, 2007
Drug discovery and development in the age of molecular medicineP Vallance, M Levick
Trends in Pharmacological Sciences|November 1, 1989
Second messenger role for NO widens to nervous and immune systemsJ Collier, P Vallance
BMJ (Clinical Research Ed.)|December 18, 2013
The real reasons for measuring patient reported outcomesAndrew J Vallance-Owen
The Journal of Hospital Infection|March 1, 1985
Antiseptic vs. saline lavage in purulent and faecal peritonitisS Vallance, R Waldron
Lancet (London, England)|January 15, 1998
Drug therapy for coronary heart disease: the Sheffield tableP Vallance, J Martin
Pageof 139

Showing results (101-110 of 1,388) with videos related to

Sort By:
Pageof 139
Critical Reviews in Clinical Laboratory Sciences|October 30, 2003
Carrier testing for autosomal-recessive disordersHilary Vallance, Jason Ford
Australasian Radiology|November 1, 1993
Retrograde venography and colour Doppler imaging of a popliteal venous aneurysmC Fernando, S Vallance
BMJ (Clinical Research Ed.)|February 16, 2008
Measuring patient care: PROMs promote health gain and patient involvementAndrew J Vallance-Owen
Journal of the American Society of Nephrology : JASN|July 1, 2005
Asymmetric dimethylarginine and kidney disease--marker or mediator?Patrick Vallance, James Leiper
Cardiovascular Research|February 1, 1994
Drugs that alter nitric oxide homeostasis: a replyP Vallance, S Moncada
Clinical Pharmacology and Therapeutics|September 14, 2007
Drug discovery and development in the age of molecular medicineP Vallance, M Levick
Trends in Pharmacological Sciences|November 1, 1989
Second messenger role for NO widens to nervous and immune systemsJ Collier, P Vallance
BMJ (Clinical Research Ed.)|December 18, 2013
The real reasons for measuring patient reported outcomesAndrew J Vallance-Owen
The Journal of Hospital Infection|March 1, 1985
Antiseptic vs. saline lavage in purulent and faecal peritonitisS Vallance, R Waldron
Lancet (London, England)|January 15, 1998
Drug therapy for coronary heart disease: the Sheffield tableP Vallance, J Martin
Pageof 139